SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-18-018699
Filing Date
2018-04-02
Accepted
2018-04-02 17:12:03
Documents
79
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tv489491_10k.htm 10-K 1446009
2 EXHIBIT 21.1 tv489491_ex21-1.htm EX-21.1 2689
3 EXHIBIT 23.1 tv489491_ex23-1.htm EX-23.1 2971
4 EXHIBIT 23.2 tv489491_ex23-2.htm EX-23.2 3174
5 EXHIBIT 31.1 tv489491_ex31-1.htm EX-31.1 8424
6 EXHIBIT 32.1 tv489491_ex32-1.htm EX-32.1 4800
  Complete submission text file 0001144204-18-018699.txt   9942730

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT imnp-20171231.xml EX-101.INS 1996055
8 XBRL TAXONOMY EXTENSION SCHEMA imnp-20171231.xsd EX-101.SCH 98938
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imnp-20171231_cal.xml EX-101.CAL 66038
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imnp-20171231_def.xml EX-101.DEF 618794
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE imnp-20171231_lab.xml EX-101.LAB 663022
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imnp-20171231_pre.xml EX-101.PRE 664757
Mailing Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632
Business Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632 201-464-2677
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36602 | Film No.: 18730062
SIC: 2834 Pharmaceutical Preparations